Evidence item

The trial found no significant active-versus-sham difference at day five or in secondary outcomes and reported good tolerability. DATASET_RESULT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 17954

Source: Low intensity transcranial electrical stimulation for schizophrenia: a triple-blind, randomized, sham-controlled multicenter trial (STIM’Zo) · locator {} · excerpt hash sha256:baeda019111ce2431380d85e70e66da924bd2f192a4ca1678396f5169d578361

Exact excerpt

At Day 5, clinical response occurred in 6/64 (9.4%) patients in the active group and 9/68 (13.2%) in the sham group, with no significant difference between groups (-0.38, 95% CI [-1.64, 0.89], p = 0.56). No significant differences were found for secondary outcomes. ... tRNS was safe and well tolerated but did not show superiority over sham in reducing persistent symptoms of schizophrenia.

Linked claims

Claim	Direction	Relevance	Steps	Counted
a31d5a31	SUPPORT	DIRECT	0	yes

Audits

None.